Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) SHH
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1385
First IPO Date
July 02, 2014
Key Executives
| Name | Title | Pay | Year Born |
| Hong Li Lin | GM & Chairman | 0 | 1993 |
| Xiusong Lin | Deputy GM, Financial Director, Director & Accounting Supervisor | 0 | 1969 |
| Hong Sheng Xu | Deputy General Manager | 0 | 1982 |
| Mingxiong Huang | Board Secretary & Director | 0 | 1993 |
Description
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is a pharmaceutical enterprise primarily engaged in the comprehensive cycle of drug development, from initial research and manufacturing to sales and distribution. The company's extensive product line addresses a wide array of therapeutic needs, covering critical medical fields such as ophthalmology, pain and fever relief (antipyretics and analgesics), anti-infective and anti-inflammatory treatments, endocrine system disorders, and cardiovascular health. Furthermore, their offerings extend to auxiliary medications, detoxification agents, treatments for urinary stones (diuretics), gynecological conditions, and intravenous solutions. These diverse pharmaceutical offerings are available across a spectrum of common dosage forms, including injectables, oral liquid preparations, eye drops, tablets, and capsules, among others. Founded in 1978, Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is headquartered in Pinghu, China.